The Future of ANCA-associated Vasculitis

被引：8
|
作者：
Holle, Julia U. [1 ]
Wieczorek, Stefan [2 ]
Gross, Wolfgang L. [1 ]
机构：
[1] Univ Hosp Schleswig Holstein, Vasc Ctr, Dept Rheumatol & Clin Immunol, D-24576 Bad Bramstedt, Germany
[2] Ruhr Univ Bochum, Dept Human Genet, D-44780 Bochum, Germany
来源：
RHEUMATIC DISEASE CLINICS OF NORTH AMERICA | 2010年 / 36卷 / 03期
关键词：
ANCA-associated vasculitis; Wegener's granulomatosis; Clinical manifestations; Treatment; ANTINEUTROPHIL CYTOPLASMIC AUTOANTIBODIES; CIRCULATING ENDOTHELIAL-CELLS; CHURG-STRAUSS-SYNDROME; WEGENERS-GRANULOMATOSIS; RANDOMIZED-TRIAL; RISK-FACTOR; DISEASE; PROTEINASE-3; ANTIBODIES; NEUTROPHILS;
D O I：
10.1016/j.rdc.2010.05.007
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The introduction of cyclophosphamide for treatment and the detection of antineutrophil cytoplasmatic antibodies (ANCA) as a seromarker for ANCA-associated vasculitis (AAV) have been the most important milestones in the history of AAV Nevertheless, there are still many issues to resolve to fully understand the pathogenesis of AAV and to improve patient outcomes There is a need for diagnostic criteria; treatment strategies need further improvement to reduce the toxicity of conventional immunosuppressants such as cyclophosphamide The elucidation of the genetic background in patients with AAV and the role of granulomatous lesions found in Wegener's granulomatosis are required to fully understand the pathophysiology of AAV
引用
收藏
页码：609 / +
页数：15
相关论文
共 50 条
  • [21] ANCA-associated renal vasculitis
    Savage, COS
    Harrington, JT
    Saville, J
    Rees, A
    Duffield, J
    Dillon, M
    Watson, A
    Powis, S
    Pusey, C
    Davison, A
    Iggo, N
    Reaich, D
    Roberts, I
    Mathieson, P
    Bone, J
    Stuart, L
    Gaskin, G
    Whitworth, C
    Ritz, E
    KIDNEY INTERNATIONAL, 2001, 60 (04) : 1614 - 1627
  • [22] Treatment of ANCA-associated vasculitis
    Wise, Matt P.
    Frost, Paul
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2007, 298 (23): : 2739 - 2740
  • [23] Epidemiology of ANCA-associated Vasculitis
    Ntatsaki, Eleana
    Watts, Richard A.
    Scott, David G. I.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (03) : 447 - +
  • [24] Updates in ANCA-associated vasculitis
    Pagnoux, Christian
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2016, 3 (03) : 122 - 133
  • [25] ANCA-associated Vasculitis Preface
    Fessler, Barri J.
    Bridges, S. Louis, Jr.
    RHEUMATIC DISEASE CLINICS OF NORTH AMERICA, 2010, 36 (03) : XIII - XIII
  • [26] RITUXIMAB IN ANCA-ASSOCIATED VASCULITIS
    Mukhtyar, Chetan
    RHEUMATOLOGY, 2013, 52 : 5 - 6
  • [27] ANCA-Associated Vasculitis With Hypocomplementemia
    Diaz Garcia, Juan D.
    Alamilla Sanchez, Mario
    Yanez Salguero, Valeria
    Yama Estrella, Martin B.
    Ortega, Jose L.
    Morales Lopez, Enrique F.
    Nieto, Julio C.
    Lopez, Claudia B.
    Ramirez, Irving G.
    Garcia Lascurain, Francisco Velasco
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2022, 33 (11): : 492 - 492
  • [28] Spectrum of ANCA-Associated Vasculitis
    Aditi Sinha
    Arvind Bagga
    The Indian Journal of Pediatrics, 2017, 84 : 737 - 738
  • [29] Refractory ANCA-associated vasculitis
    Gopaluni, Seerapani
    Egan, Allyson C.
    Xipell, Marc
    Jayne, David R. W.
    RHEUMATOLOGY, 2021, 60 : 63 - 66
  • [30] Classification of ANCA-Associated Vasculitis
    Khan, Irfan
    Watts, Richard A.
    CURRENT RHEUMATOLOGY REPORTS, 2013, 15 (12)
12345